Phase 1 study of AG-881, an inhibitor of mutant IDH1 and IDH2: Results from the recurrent/progressive glioma population Meeting Abstract
| Authors: | Mellinghoff, I.; Penas-Prado, M.; Peters, K.; Cloughesy, T.; Burris, H.; Maher, E.; Janku, F.; Cote, G.; De La Fuente, M.; Clarke, J.; Steelman, L.; Le, K.; Xu, H.; Sonderfan, A.; Hummel, D.; Schoenfeld, S.; Yen, K.; Pandya, S.; Wen, P. |
| Abstract Title: | Phase 1 study of AG-881, an inhibitor of mutant IDH1 and IDH2: Results from the recurrent/progressive glioma population |
| Meeting Title: | 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 20 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2018 Nov 15-18 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | vi18 |
| Language: | English |
| ACCESSION: | WOS:000460646300066 |
| PROVIDER: | wos |
| PMCID: | PMC6216117 |
| DOI: | 10.1093/neuonc/noy148 |
| Notes: | Meeting Abstract: ACTR-31 -- Source: Wos |
